Market Overview:
The global ticarcillin disodium and clavulanate potassium for injection market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of animal muscle pain, animal febrile disease, and other applications. North America is expected to dominate the global ticarcillin disodium and clavulanate potassium for injection market in terms of revenue during the forecast period. Asia Pacific is projected to be the fastest growing region in terms of CAGR during the forecast period.
Product Definition:
Ticarcillin Disodium and Clavulanate Potassium For Injection is a combination antibiotic used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria.
10ml/Dose:
10ml/Dose, it's usage and growth factor in Ticarcillin Disodium and Clavulanate Potassium For Injection market is segmented on the basis of product type into 10 ml/dose ampoules, vials & ampoules.
20ml/ Dose:
20ml/dose and it's usage in Ticarcillin Disodium and Clavulanate Potassium For Injection is used for the treatment of urinary tract infections, skin infections, respiratory tract infections, ear infection and tonsillitis.
20ml/ dose contains ticarcillin sodium salt (Clavulanate potassium) which is an antibiotic medication used to treat bacterial cystitis in women.
Application Insights:
Animal muscle pain held the largest share of the global market in 2017. Ticarcillin is used for treating animal muscle pain caused by bacterial infection. It works by killing off the bacteria that cause animal muscle pain. The product is widely used for poultry and livestock infections as well as for pet infections, which accounts for its large share in human medicine application segment also. However, other applications such as respiratory diseases and skin diseases are expected to grow at a faster rate during the forecast period owing to increasing R&D initiatives on ticarcillin-based drugs with new indications every year since 2014 (i.e., ticarcillinum potassium injection).
Regional Analysis:
Asia Pacific dominated the global market in 2017, with a revenue share of over 38.0%. The presence of emerging economies such as China and India is anticipated to boost the demand for antibiotics during the forecast period. In addition, increasing animal population and meat consumption are also expected to drive regional growth over the coming years.
The market in North America is expected to grow at a significant rate due to rising incidence of chronic diseases among animals coupled with growing awareness about animal health & well-being. Moreover, government initiatives for promoting livestock production are likely to have a positive impact on industry growth over the next eight years.
In Europe, countries such as Spain and Italy dominate livestock production owing to favorable climatic conditions required for year-round farming activities comparedto other regions across globe’s surface (excluding Polar regions). This factor is anticipatedto enhance product penetration rates within this region during forecast period; however declining trend observedin recent years may hamper future growth prospects in near future.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the Ticarcillin Disodium and Clavulanate Potassium For Injection market. This is because Ticarcillin Disodium and Clavulanate Potassium are effective in treating a wide range of infections caused by bacteria.
- Rising demand for combination therapies: The rising demand for combination therapies is another key growth driver for the Ticarcillin Disodium and Clavulanate Potassium For Injection market. This is because combination therapies offer better efficacy as compared to monotherapy, thus resulting in better patient outcomes.
- Growing number of product approvals: The growing number of product approvals is another key factor driving the growth of the Ticarcillin Disodium and Clavulanate Potassium For Injection market. This is because with more products getting approved, manufacturers are able to cater to a wider customer base, thereby expanding their business reach.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ticarcillin Disodium and Clavulanate Potassium For Injection Market Research Report
By Type
10ml/Dose, 20ml/ Dose
By Application
Animal muscle pain, Animal febrile disease, Others
By Companies
Norbrook, Zoteis, Merck Animal Health, Virbac Animal Health India Private Limited, MSD Animal Health, Bengal Remedies Limited, Wuhan Huisheng Biological Technology Co., Ltd., Qilu Animal Health Products Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
147
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market Report Segments:
The global Ticarcillin Disodium and Clavulanate Potassium For Injection market is segmented on the basis of:
Types
10ml/Dose, 20ml/ Dose
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Animal muscle pain, Animal febrile disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Norbrook
- Zoteis
- Merck Animal Health
- Virbac Animal Health India Private Limited
- MSD Animal Health
- Bengal Remedies Limited
- Wuhan Huisheng Biological Technology Co., Ltd.
- Qilu Animal Health Products Co., Ltd.
- Baimukang Animal Pharmaceutical Co., Ltd.
- Shandong Zhongmu Veterinary Medicine Co., Ltd.
- Hebei New Century Pharmaceutical Co., Ltd.
- Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
- Shandong Lukang Pharmaceutical Co., Ltd.
Highlights of The Ticarcillin Disodium and Clavulanate Potassium For Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10ml/Dose
- 20ml/ Dose
- By Application:
- Animal muscle pain
- Animal febrile disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ticarcillin Disodium and Clavulanate Potassium For Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ticarcillin Disodium and Clavulanate Potassium Injection is a combination antibiotic medication used to treat infections caused by bacteria. It is made up of ticarcillin (a type of penicillin) and clavulanate potassium (a type of cephalosporin).
Some of the major companies in the ticarcillin disodium and clavulanate potassium for injection market are Norbrook, Zoteis, Merck Animal Health, Virbac Animal Health India Private Limited, MSD Animal Health, Bengal Remedies Limited, Wuhan Huisheng Biological Technology Co., Ltd., Qilu Animal Health Products Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd..
The ticarcillin disodium and clavulanate potassium for injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ticarcillin Disodium and Clavulanate Potassium For Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ticarcillin Disodium and Clavulanate Potassium For Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ticarcillin Disodium and Clavulanate Potassium For Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ticarcillin Disodium and Clavulanate Potassium For Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market Size & Forecast, 2020-2028
4.5.1 Ticarcillin Disodium and Clavulanate Potassium For Injection Market Size and Y-o-Y Growth
4.5.2 Ticarcillin Disodium and Clavulanate Potassium For Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10ml/Dose
5.2.2 20ml/ Dose
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Animal muscle pain
6.2.2 Animal febrile disease
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ticarcillin Disodium and Clavulanate Potassium For Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10ml/Dose
9.6.2 20ml/ Dose
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Animal muscle pain
9.10.2 Animal febrile disease
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10ml/Dose
10.6.2 20ml/ Dose
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Animal muscle pain
10.10.2 Animal febrile disease
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10ml/Dose
11.6.2 20ml/ Dose
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Animal muscle pain
11.10.2 Animal febrile disease
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10ml/Dose
12.6.2 20ml/ Dose
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Animal muscle pain
12.10.2 Animal febrile disease
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10ml/Dose
13.6.2 20ml/ Dose
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Animal muscle pain
13.10.2 Animal febrile disease
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ticarcillin Disodium and Clavulanate Potassium For Injection Market: Competitive Dashboard
14.2 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Norbrook
14.3.2 Zoteis
14.3.3 Merck Animal Health
14.3.4 Virbac Animal Health India Private Limited
14.3.5 MSD Animal Health
14.3.6 Bengal Remedies Limited
14.3.7 Wuhan Huisheng Biological Technology Co., Ltd.
14.3.8 Qilu Animal Health Products Co., Ltd.
14.3.9 Baimukang Animal Pharmaceutical Co., Ltd.
14.3.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
14.3.11 Hebei New Century Pharmaceutical Co., Ltd.
14.3.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
14.3.13 Shandong Lukang Pharmaceutical Co., Ltd.
